Effect of traditional medicine product based on Rosa damascena on gastroesophageal reflux disease (GERD)

Phase 3

Recruiting

• Conditions: gastroesophageal reflux.; Gastro-esophageal reflux disease

• Registration Number: IRCT20200303046677N5
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

With reflux at the age of 18 to 80 years

Exclusion Criteria

Having a history of Barrett's esophagus
History of esophageal or gastric surgery
History of esophageal, gastric or abdominal cancer
Having coagulation problems that prevent them from stopping their medication
Patients receiving regular glucocorticoids and nonsteroidal anti-inflammatory drugs more than three days a week for the past 28 days
Receiving sucralfate three days before enrollment
Take aspirin daily at a dose of more than 150 mg
Acute peptic ulcer or its complications
Receive antibiotic treatment to eradicate Helicobacter Pylori in the last 28 days
Smoking or Alcohol

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Heartburn. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Reflux throat. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Pain in the middle and upper stomach. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Nausea. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.;Difficulty in falling asleep due to reflux symptoms. Timepoint: On arrival, the second week and fourth week. Method of measurement: Questionnaire.